Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Prostate Cancer Screening market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Prostate Cancer Screeningmarket, defines the market attractiveness level of Prostate Cancer Screening market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Prostate Cancer Screening industry, describes the types of Prostate Cancer Screening market, the applications of major players and the market size, and deeply analyzes the current situation of the global Prostate Cancer Screening market and the development prospects and opportunities of Prostate Cancer Screening industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Prostate Cancer Screening market in Chapter 13.
By Player:
Genomic Health
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientific
BioméRieux
Mdxhealth
Hologic
Almac
Bayer
Myriad Genetics
Rosetta Genomics
Beckman Coulter
Mayo Clinic
By Type:
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
By End-User:
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Prostate Cancer Screening Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Prostate Cancer Screening Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Prostate Cancer Screening Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Prostate Cancer Screening Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Prostate Cancer Screening Market Analysis and Outlook to 2022
-
7.1 Global Prostate Cancer Screening Consumption (2017-2022)
-
7.2 United States Prostate Cancer Screening Consumption (2017-2022)
-
7.3 Europe Prostate Cancer Screening Consumption (2017-2022)
-
7.4 China Prostate Cancer Screening Consumption (2017-2022)
-
7.5 Japan Prostate Cancer Screening Consumption (2017-2022)
-
7.6 India Prostate Cancer Screening Consumption (2017-2022)
-
7.7 South Korea Prostate Cancer Screening Consumption (2017-2022)
8 Region and Country-wise Prostate Cancer Screening Market Analysis and Outlook to 2028
-
8.1 Global Prostate Cancer Screening Consumption Forecast (2022-2028)
-
8.2 United States Prostate Cancer Screening Consumption Forecast (2022-2028)
-
8.3 Europe Prostate Cancer Screening Consumption Forecast (2022-2028)
-
8.4 China Prostate Cancer Screening Consumption Forecast (2022-2028)
-
8.5 Japan Prostate Cancer Screening Consumption Forecast (2022-2028)
-
8.6 India Prostate Cancer Screening Consumption Forecast (2022-2028)
-
8.7 South Korea Prostate Cancer Screening Consumption Forecast (2022-2028)
9 Global Prostate Cancer Screening Market Outlook by Types and Applications to 2022
-
9.1 Global Prostate Cancer Screening Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Physical Exam Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Laboratory Tests Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Imaging Tests Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Gleason Score Consumption and Growth Rate (2017-2022)
-
9.1.5 Global TNM Score Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Genetic Tests Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Digital Rectal Exam Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Biopsy Consumption and Growth Rate (2017-2022)
-
9.2 Global Prostate Cancer Screening Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Labs Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cancer Institutes Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Prostate Cancer Screening Market Outlook by Types and Applications to 2028
-
10.1 Global Prostate Cancer Screening Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Physical Exam Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Laboratory Tests Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Imaging Tests Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Gleason Score Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global TNM Score Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Genetic Tests Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Digital Rectal Exam Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Prostate Cancer Screening Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Labs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cancer Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Prostate Cancer Screening Import and Export Analysis (Top 5 Countries)
-
11.1 Global Prostate Cancer Screening Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Prostate Cancer Screening Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Prostate Cancer Screening Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Prostate Cancer Screening Market Competitive Analysis
-
14.1 Genomic Health
-
14.1.1 Genomic Health Company Details
-
14.1.2 Genomic Health Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Genomic Health Prostate Cancer Screening Product and Service
-
14.2 Abbott Laboratories
-
14.2.1 Abbott Laboratories Company Details
-
14.2.2 Abbott Laboratories Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Laboratories Prostate Cancer Screening Product and Service
-
14.3 Roche Diagnostics
-
14.3.1 Roche Diagnostics Company Details
-
14.3.2 Roche Diagnostics Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Diagnostics Prostate Cancer Screening Product and Service
-
14.4 Thermo Fisher Scientific
-
14.4.1 Thermo Fisher Scientific Company Details
-
14.4.2 Thermo Fisher Scientific Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Thermo Fisher Scientific Prostate Cancer Screening Product and Service
-
14.5 BioméRieux
-
14.5.1 BioméRieux Company Details
-
14.5.2 BioméRieux Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 BioméRieux Prostate Cancer Screening Product and Service
-
14.6 Mdxhealth
-
14.6.1 Mdxhealth Company Details
-
14.6.2 Mdxhealth Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mdxhealth Prostate Cancer Screening Product and Service
-
14.7 Hologic
-
14.7.1 Hologic Company Details
-
14.7.2 Hologic Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Hologic Prostate Cancer Screening Product and Service
-
14.8 Almac
-
14.8.1 Almac Company Details
-
14.8.2 Almac Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Almac Prostate Cancer Screening Product and Service
-
14.9 Bayer
-
14.9.1 Bayer Company Details
-
14.9.2 Bayer Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bayer Prostate Cancer Screening Product and Service
-
14.10 Myriad Genetics
-
14.10.1 Myriad Genetics Company Details
-
14.10.2 Myriad Genetics Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Myriad Genetics Prostate Cancer Screening Product and Service
-
14.11 Rosetta Genomics
-
14.11.1 Rosetta Genomics Company Details
-
14.11.2 Rosetta Genomics Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Rosetta Genomics Prostate Cancer Screening Product and Service
-
14.12 Beckman Coulter
-
14.12.1 Beckman Coulter Company Details
-
14.12.2 Beckman Coulter Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Beckman Coulter Prostate Cancer Screening Product and Service
-
14.13 Mayo Clinic
-
14.13.1 Mayo Clinic Company Details
-
14.13.2 Mayo Clinic Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Mayo Clinic Prostate Cancer Screening Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Prostate Cancer Screening
-
Figure Prostate Cancer Screening Picture
-
Table Global Prostate Cancer Screening Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prostate Cancer Screening Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Prostate Cancer Screening Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Prostate Cancer Screening Consumption by Country (2017-2022)
-
Figure United States Prostate Cancer Screening Consumption and Growth Rate (2017-2022)
-
Table Europe Prostate Cancer Screening Consumption and Growth Rate (2017-2022)
-
Figure China Prostate Cancer Screening Consumption and Growth Rate (2017-2022)
-
Figure Japan Prostate Cancer Screening Consumption and Growth Rate (2017-2022)
-
Figure India Prostate Cancer Screening Consumption and Growth Rate (2017-2022)
-
Figure South Korea Prostate Cancer Screening Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Screening Consumption Forecast by Country (2022-2028)
-
Figure United States Prostate Cancer Screening Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Prostate Cancer Screening Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Prostate Cancer Screening Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Prostate Cancer Screening Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Prostate Cancer Screening Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Prostate Cancer Screening Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Physical Exam Consumption and Growth Rate (2017-2022)
-
Figure Global Laboratory Tests Consumption and Growth Rate (2017-2022)
-
Figure Global Imaging Tests Consumption and Growth Rate (2017-2022)
-
Figure Global Gleason Score Consumption and Growth Rate (2017-2022)
-
Figure Global TNM Score Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Tests Consumption and Growth Rate (2017-2022)
-
Figure Global Digital Rectal Exam Consumption and Growth Rate (2017-2022)
-
Figure Global Biopsy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Labs Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Physical Exam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Laboratory Tests Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Imaging Tests Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gleason Score Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global TNM Score Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Tests Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Digital Rectal Exam Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopsy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Labs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Prostate Cancer Screening Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Prostate Cancer Screening Export by Region (Top 5 Countries) (2017-2028)
-
Table Genomic Health (Foundation Year, Company Profile and etc.)
-
Table Genomic Health Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genomic Health Prostate Cancer Screening Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Prostate Cancer Screening Product and Service
-
Table Roche Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Roche Diagnostics Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Diagnostics Prostate Cancer Screening Product and Service
-
Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)
-
Table Thermo Fisher Scientific Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Thermo Fisher Scientific Prostate Cancer Screening Product and Service
-
Table BioméRieux (Foundation Year, Company Profile and etc.)
-
Table BioméRieux Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioméRieux Prostate Cancer Screening Product and Service
-
Table Mdxhealth (Foundation Year, Company Profile and etc.)
-
Table Mdxhealth Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mdxhealth Prostate Cancer Screening Product and Service
-
Table Hologic (Foundation Year, Company Profile and etc.)
-
Table Hologic Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hologic Prostate Cancer Screening Product and Service
-
Table Almac (Foundation Year, Company Profile and etc.)
-
Table Almac Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Almac Prostate Cancer Screening Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Prostate Cancer Screening Product and Service
-
Table Myriad Genetics (Foundation Year, Company Profile and etc.)
-
Table Myriad Genetics Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myriad Genetics Prostate Cancer Screening Product and Service
-
Table Rosetta Genomics (Foundation Year, Company Profile and etc.)
-
Table Rosetta Genomics Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rosetta Genomics Prostate Cancer Screening Product and Service
-
Table Beckman Coulter (Foundation Year, Company Profile and etc.)
-
Table Beckman Coulter Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beckman Coulter Prostate Cancer Screening Product and Service
-
Table Mayo Clinic (Foundation Year, Company Profile and etc.)
-
Table Mayo Clinic Prostate Cancer Screening Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mayo Clinic Prostate Cancer Screening Product and Service
-
